Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Florida
Medical College of Wisconsin
First Affiliated Hospital of Zhejiang University
IRCCS San Raffaele
Rush University Medical Center
University of Washington
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Pfizer
University of Maryland, Baltimore
Mayo Clinic
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute
St. Jude Children's Research Hospital
Hospital Israelita Albert Einstein
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
M.D. Anderson Cancer Center
Washington University School of Medicine
University of Chicago
National Cancer Institute (NCI)
Texas Oncology Cancer Center
Case Comprehensive Cancer Center
Baylor Research Institute
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center